Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

by Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Published 2013

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

by Stephen, J, Murray, G, Cameron, D A, Thomas, J, Kunkler, I H, Jack, W, Kerr, G R, Piper, T, Brookes, C L, Rea, D W, van de Velde, C J H, Hasenburg, A, Markopoulos, C, Dirix, L, Seynaeve, C, Bartlett, J M S
Published 2014